CBG Passing Score 2026: Exactly What You Need to Pass

What the Official Sources Do and Do Not Say About Scoring

Searching for the "CBG passing score" turns up a lot of confident numbers. Before you anchor your preparation to any of them, it helps to know exactly what the certifying body has published for Clinical Biochemical Genetics.

The American Board of Medical Genetics and Genomics (ABMGG) publishes content outlines and blueprints for each specialty. For biochemical genetics, the current source document is the ABMGG Biochemical Genetics Blueprint and Content Codes, effective August 2025. That document defines the exam content categories and their approximate weights. What it does not give us, in the material reviewed for this article, is a numeric cut score, a scaled-score range, or a percent-correct threshold.

This matters because the biggest risk for candidates is not an unknown cut score; it is studying toward a fabricated one. A candidate who believes "70% gets me through" may under-prepare in precisely the categories where this exam is hard. Treat the pass standard as a competence judgment across the whole blueprint rather than a number you can reverse-engineer.

If you want context on how candidates experience the difficulty, see our guide on how hard the CBG exam is, and for outcome data (as far as it is publicly available) read our write-up on the CBG pass rate.

How the Blueprint Weights Shape Your Score

Even without a published cut score, the blueprint tells you where the points live. The fifteen categories and their published approximate percentages are:

Add those up and you get 102%, not 100%. That discrepancy is in the source itself, and we have preserved the numbers as published rather than normalizing them. The practical reading: these are approximate emphasis levels, not a guarantee that exactly 15 of every 100 items come from amino acids. Use them to prioritize, not to calculate a safe number of items you can afford to miss.

For a category-by-category breakdown of what each area contains, our complete guide to all 15 CBG content areas goes deeper than we can here.

The Domains That Carry the Most Points

Five categories together account for roughly 62% of the published emphasis: Amino acids, Lipids, Organic acids, Lysosomes, and Carbohydrates. If you are strong here, you have built most of the foundation a passing result requires. If you are weak here, no amount of mastery of small categories will rescue you.

Notice the cross-category boundaries: GSD II sits under lysosomes, and cobalamin-related methylmalonic defects sit under cofactors. Knowing where the blueprint files a disorder helps you study efficiently and avoid duplicated effort.

Low-Weight Domains That Still Cost Candidates

Because the passing standard is not published as a simple percentage, no one can tell you that skipping a category is "safe." Small categories are small, but they are also the ones candidates tend to leave blank, and a blank category is a guaranteed run of missed items. Several low-weight areas are also compact enough to master quickly.

• Cofactors (7%): cobalamin, biotin, molybdenum, folate, pyridoxine, biopterin, and others including riboflavin, niacin, and thiamine. These link back to organic acid and amino acid patterns, so studying them pays double.
• Mitochondria (7%): mitochondrial myopathies (including Leigh syndrome and adult presentations), electron transport chain function and assembly, mtDNA mutation, maintenance, and depletion disorders, and MELAS.
• Peroxisomes (3%): Zellweger syndrome and other biogenesis disorders, X-linked adrenoleukodystrophy, and Refsum-related conditions.
• Purines and pyrimidines (3%): Lesch-Nyhan disease, adenosine deaminase deficiency, UMP synthase deficiency.
• Transport (3%): cystinuria, lysinuric protein intolerance, other amino acid transport, glucose and carnitine.
• Metals (3%): Wilson disease, Menkes disease, iron, zinc.
• Neurotransmitters (2%) and Creatine (1%): SSADH deficiency, dopamine synthesis disorders, GABA metabolism, and the creatine category.

The Laboratory Domain: Where Technical Judgment Is Scored

At 8%, the Laboratory category is larger than Mitochondria or Cofactors, and it tests a different kind of thinking. It covers QA/QC, artifact, techniques, and regulations. Candidates who come from a purely clinical background and have spent little time on the bench often underestimate it.

Artifact is the sneakiest piece. A profile that looks like a metabolic disorder may be explained by something else entirely, and the exam expects you to know the difference. Pair every disease you study with the question: "What could produce this result without the disease being present?"

Timing and the Odd-Year Biochemical Schedule

Scoring is only half the logistics. Timing determines how long you have to build the competence the exam demands. ABMGG has approved a transition to an annual certifying examination schedule, but biochemical specialties are offered in odd years. The next Clinical Biochemical Genetics exam is identified as August 2027, with ABMGG announcing certification exams for August 11-14, 2027.

Two things follow from this. First, there is no 2026 sitting for this specialty, which means any 2026 timeline is preparation time rather than test time. Second, because the cadence is every other year, a missed attempt carries a long wait, which raises the stakes of arriving fully prepared the first time. For dates, windows, and scheduling detail, see our guide to CBG exam dates, and for eligibility see CBG requirements.

Fee amounts, question count, and timer length were not established in the supplied official content, so we do not state them. Our CBG certification cost breakdown covers what is and is not confirmed on pricing.

Sequencing Your Preparation Around the Blueprint

With a long runway before August 2027, the question is order. Because a numeric cut score is unavailable, the sound approach is to secure the high-weight categories first, then close gaps in everything else. Here is one sequencing model tied directly to the blueprint rather than to generic study theory.

Practice under realistic conditions as you near the exam. Our CBG practice tests let you check where your reasoning breaks down by category, which is far more useful than a single overall percentage.

Score Myths to Ignore

Several claims circulate about passing scores for this credential. Here is how to handle them.

• "You need exactly X% to pass." Without a published figure in the official blueprint materials, any specific percentage is unverified. Do not plan around it.
• "You can skip the small categories." Those categories collectively represent a meaningful share of the published emphasis, and the cut score is unknown. Skipping them is a risk, not a strategy.
• "The weights tell you exactly how many items per category." The published percentages sum to 102%, which confirms they are approximate guides, not precise item counts.
• "Another CBG exam's numbers apply here." Several unrelated credentials share the acronym. Fees, dates, and scoring from any of them do not apply to Clinical Biochemical Genetics certified through ABMGG. Verify everything against ABMGG's own pages.

It is also worth remembering that the blueprint categories are exam objectives, not a substitute for broad preparation resources or performance-only training. Treat the blueprint as a map of what is tested, and fill each region with real depth from textbooks, case literature, and hands-on laboratory experience.

If you are weighing whether the effort is justified, our analysis of whether the CBG certification is worth it and our CBG salary guide cover the career side, and CBG jobs looks at where certified professionals work.

Frequently Asked Questions